These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23572414)

  • 1. Increased basal nitric oxide amplifies the association of inflammation with all-cause and cardiovascular mortality in prevalent hemodialysis patients.
    Beberashvili I; Sinuani I; Azar A; Kadoshi H; Shapiro G; Feldman L; Sandbank J; Averbukh Z
    Int Urol Nephrol; 2013 Dec; 45(6):1703-13. PubMed ID: 23572414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased IGF-1 levels potentiate association of inflammation with all-cause and cardiovascular mortality in prevalent hemodialysis patients.
    Beberashvili I; Sinuani I; Azar A; Kadoshi H; Shapiro G; Feldman L; Sandbank J; Averbukh Z
    Growth Horm IGF Res; 2013 Dec; 23(6):209-14. PubMed ID: 23958273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between acyl-ghrelin and BMI predicts clinical outcomes in hemodialysis patients.
    Beberashvili I; Sinuani I; Azar A; Shapiro G; Feldman L; Doenyas-Barak K; Stav K; Efrati S
    BMC Nephrol; 2017 Jan; 18(1):29. PubMed ID: 28100170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients.
    Tripepi G; Mattace Raso F; Sijbrands E; Seck MS; Maas R; Boger R; Witteman J; Rapisarda F; Malatino L; Mallamaci F; Zoccali C
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1714-21. PubMed ID: 21642364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal changes in bioimpedance phase angle reflect inverse changes in serum IL-6 levels in maintenance hemodialysis patients.
    Beberashvili I; Azar A; Sinuani I; Kadoshi H; Shapiro G; Feldman L; Sandbank J; Averbukh Z
    Nutrition; 2014 Mar; 30(3):297-304. PubMed ID: 24484680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decoy receptor 3, a novel inflammatory marker, and mortality in hemodialysis patients.
    Hung SC; Hsu TW; Lin YP; Tarng DC
    Clin J Am Soc Nephrol; 2012 Aug; 7(8):1257-65. PubMed ID: 22626963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
    Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients.
    Honda H; Ueda M; Kojima S; Mashiba S; Michihata T; Takahashi K; Shishido K; Akizawa T
    Atherosclerosis; 2012 Feb; 220(2):493-501. PubMed ID: 22119537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
    Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
    Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-6 levels, nutritional status, and mortality in prevalent hemodialysis patients.
    Beberashvili I; Sinuani I; Azar A; Yasur H; Shapiro G; Feldman L; Averbukh Z; Weissgarten J
    Clin J Am Soc Nephrol; 2011 Sep; 6(9):2253-63. PubMed ID: 21852667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy-associated plasma protein-A predicts survival in end-stage renal disease-confounding and modifying effects of cardiovascular disease, body composition and inflammation.
    Nilsson E; Cao Y; Lindholm B; Ohyama A; Carrero JJ; Qureshi AR; Stenvinkel P
    Nephrol Dial Transplant; 2018 Jun; 33(6):971-977. PubMed ID: 28992321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive effects of soluble TWEAK and inflammation on mortality in hemodialysis patients.
    Carrero JJ; Ortiz A; Qureshi AR; Martín-Ventura JL; Bárány P; Heimbürger O; Marrón B; Metry G; Snaedal S; Lindholm B; Egido J; Stenvinkel P; Blanco-Colio LM
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):110-8. PubMed ID: 18945991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between leptin and all-cause and cardiovascular mortality in chronic hemodialysis patients.
    Díez JJ; Bossola M; Fernández-Reyes MJ; Di Stasio E; Tazza L; Luciani G; Codoceo R; Iglesias P; Rodríguez A; González E; Selgas R
    Nefrologia; 2011; 31(2):206-12. PubMed ID: 21461015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Obestatin: A Biomarker of Cardiovascular and All-Cause Mortality in Hemodialysis Patients.
    Beberashvili I; Katkov A; Sinuani I; Azar A; Shapiro G; Feldman L; Gorelik O; Stav K; Efrati S
    Am J Nephrol; 2018; 47(4):254-265. PubMed ID: 29694945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Adiponectin With Body Composition and Mortality in Hemodialysis Patients.
    Rhee CM; Nguyen DV; Moradi H; Brunelli SM; Dukkipati R; Jing J; Nakata T; Kovesdy CP; Brent GA; Kalantar-Zadeh K
    Am J Kidney Dis; 2015 Aug; 66(2):313-21. PubMed ID: 25824125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal Study of Serum Uric Acid, Nutritional Status, and Mortality in Maintenance Hemodialysis Patients.
    Beberashvili I; Erlich A; Azar A; Sinuani I; Feldman L; Gorelik O; Stav K; Efrati S
    Clin J Am Soc Nephrol; 2016 Jun; 11(6):1015-1023. PubMed ID: 27026520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of trimethylamine
    Zhang P; Zou JZ; Chen J; Tan X; Xiang FF; Shen B; Hu JC; Wang JL; Wang YQ; Yu JB; Nie YX; Chen XH; Yu JW; Zhang Z; Lv WL; Xie YQ; Cao XS; Ding XQ
    Ren Fail; 2020 Nov; 42(1):1004-1014. PubMed ID: 32985309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-energy wasting modifies the association of ghrelin with inflammation, leptin, and mortality in hemodialysis patients.
    Carrero JJ; Nakashima A; Qureshi AR; Lindholm B; Heimbürger O; Bárány P; Stenvinkel P
    Kidney Int; 2011 Apr; 79(7):749-56. PubMed ID: 21178976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geriatric nutritional risk index, muscle function, quality of life and clinical outcome in hemodialysis patients.
    Beberashvili I; Azar A; Sinuani I; Shapiro G; Feldman L; Sandbank J; Stav K; Efrati S
    Clin Nutr; 2016 Dec; 35(6):1522-1529. PubMed ID: 27117682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients.
    Rao M; Guo D; Perianayagam MC; Tighiouart H; Jaber BL; Pereira BJ; Balakrishnan VS
    Am J Kidney Dis; 2005 Feb; 45(2):324-33. PubMed ID: 15685511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.